All terms in GO
| Label | Id | Description |
|---|---|---|
| obsolete chanoclavine-I catabolic process | GO_1900565 |
OBSOLETE. The chemical reactions and pathways resulting in the breakdown of chanoclavine-I.
|
| GO_0015542 | GO_0015542 | |
| obsolete chanoclavine-I biosynthetic process | GO_1900566 |
OBSOLETE. The chemical reactions and pathways resulting in the formation of chanoclavine-I.
|
| obsolete lactose/glucose efflux transporter activity | GO_0015543 |
OBSOLETE. Catalysis of the reaction: glucose or lactose(in) = glucose or lactose(out).
|
| chanoclavine-I aldehyde metabolic process | GO_1900567 |
The chemical reactions and pathways involving chanoclavine-I aldehyde.
|
| 3-hydroxyphenyl propionate:proton symporter activity | GO_0015540 |
Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: 3-hydroxyphenyl propionate(out) + H+(out) = 3-hydroxyphenyl propionate(in) + H+(in).
|
| 3-hydroxyphenyl propanoate transmembrane transporter activity | GO_0015551 |
Enables the transfer of 3-hydroxyphenyl propanoate from one side of a membrane to the other.
|
| obsolete chanoclavine-I aldehyde catabolic process | GO_1900568 |
OBSOLETE. The chemical reactions and pathways resulting in the breakdown of chanoclavine-I aldehyde.
|
| secondary active cyanate transmembrane transporter activity | GO_0015541 |
Enables the transfer of cyanate from one side of a membrane to the other.
|
| cyanate transmembrane transporter activity | GO_0015110 |
Enables the transfer of cyanate, NCO-, the anion of cyanic acid, from one side of a membrane to the other.
|
| chanoclavine-I aldehyde biosynthetic process | GO_1900569 |
The chemical reactions and pathways resulting in the formation of chanoclavine-I aldehyde. Chanoclavine-I aldehyde is at a branching point in the biosynthetic pathways of fumigaclavine C and ergotamine.
|
| GO_0015559 | GO_0015559 | |
| modulation by symbiont of host apoptotic process | GO_0052150 |
Any process in which an organism modulates the frequency, rate or extent of programmed cell death in the host, where programmed cell death proceeds by apoptosis. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
| suppression by virus of host TRAF-mediated signal transduction | GO_0039527 |
Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of TRAF-mediated signal transduction in the host.
|
| GO_0015557 | GO_0015557 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO_0039528 |
The series of molecular signals initiated by the binding of a virus or viral RNA binding to a pattern recognition receptor (PRR) located in the cytoplasm. Cytosolic PRRs such as RIG-I (DDX58) and MDA-5 (IFIH1) detect RNA synthesized during active viral replication and trigger a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.
|
| secondary active p-aminobenzoyl-glutamate transmembrane transporter activity | GO_0015558 |
Enables the transfer of p-aminobenzoyl-glutamate from one side of a membrane to the other, up its concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction and is driven by a chemiosmotic source of energy. Secondary active transporters include symporters and antiporters. p-aminobenzoyl-glutamate is the anion of p-aminobenzoyl-glutamic acid.
|
| dipeptide transmembrane transporter activity | GO_0071916 |
Enables the transfer of a dipeptide from one side of a membrane to the other. A dipeptide is a combination of two amino acids linked together by a peptide (-CO-NH-) bond.
|
| RIG-I signaling pathway | GO_0039529 |
The series of molecular signals initiated by the binding of viral RNA to a pattern recognition receptor (PRR) RIG-1 (also known as DDX58). RIG-I is a cytoplasmic receptor that detects RNA synthesized during viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.
|
| GO_0015555 | GO_0015555 |